ToxReason: A Benchmark for Mechanistic Chemical Toxicity Reasoning via Adverse Outcome Pathway
Summary: arXiv:2604.06264v1 Announce Type: cross
Introduction
Recent advancements in large language models (LLMs) have paved the way for molecular reasoning related to property prediction in various fields, including chemistry and toxicology. While these models are proficient in generating predictions based on chemical structures, the complexity of toxicity mechanisms necessitates a more nuanced approach. Toxicity often arises from intricate biological processes that extend beyond mere chemical composition, highlighting the need for mechanistic reasoning to enhance prediction reliability.
The Challenge
Despite the significance of mechanistic reasoning in toxicity prediction, existing benchmarks fail to provide a systematic evaluation of this capability. Many current models can produce fluent explanations; however, these explanations are not always biologically accurate. As a result, it becomes challenging to determine whether predicted toxicities are grounded in valid biological mechanisms or are merely speculative outputs. This discrepancy points to an urgent need for a robust framework that can effectively assess and enhance the mechanistic reasoning capabilities of LLMs.
Introducing ToxReason
To address the aforementioned challenges, we introduce ToxReason, a novel benchmark designed to evaluate organ-level toxicity reasoning based on the Adverse Outcome Pathway (AOP) framework. ToxReason incorporates experimental evidence of drug-target interactions along with toxicity labels, compelling models to infer both toxic outcomes and their underlying mechanisms. This process spans from the Molecular Initiating Event (MIE) to the Adverse Outcome (AO), thereby creating a comprehensive evaluation of the models’ reasoning capabilities.
Evaluation Methodology
ToxReason serves as a critical tool for assessing toxicity prediction performance and reasoning quality across diverse LLMs. The benchmark facilitates a thorough examination of how well these models can link molecular events to adverse outcomes while accurately reflecting the biological processes involved. Key aspects of the evaluation include:
- Integration of experimental data to ensure grounding in biological reality.
- Assessment of reasoning quality in relation to predictive performance.
- Comparative analysis across various LLM architectures to identify strengths and weaknesses.
Key Findings
Our analysis reveals that strong predictive performance does not necessarily correlate with reliable mechanistic reasoning. This finding underscores the critical distinction between generating accurate predictions and providing biologically faithful explanations. Moreover, our research indicates that training models with a focus on reasoning awareness significantly enhances mechanistic reasoning capabilities. As a result, this improved reasoning quality subsequently boosts overall toxicity prediction performance.
Conclusion
The introduction of ToxReason highlights the essential need for integrating reasoning into both the evaluation and training processes of toxicity modeling. By establishing a benchmark grounded in the Adverse Outcome Pathway, we aim to foster the development of more reliable and biologically relevant predictive models. As the field of toxicology continues to evolve, such advancements are crucial for ensuring the safety and efficacy of chemical compounds.
In conclusion, ToxReason represents a significant step forward in bridging the gap between predictive accuracy and mechanistic understanding, ultimately contributing to safer chemical practices and improved public health outcomes.